This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The FDA approved nitisinone (Harliku) for the reduction of urine homogentisic acid (HGA) in patients with alkaptonuria (AKU). The FDA approved nitisinone (Harliku) for the reduction of urine homogentisic acid (HGA) in patients with alkaptonuria (AKU). The medication is expected to launch in July 2025. REFERENCES 1.
The FDA approved telmisartan, amlodipine and indapamide (Widaplik) for the treatment of hypertension in adult patients, George Medicines said in a release. The FDA approved telmisartan, amlodipine and indapamide (Widaplik) for the treatment of hypertension in adult patients, George Medicines said in a release. References 1.
The Potential Impact Pharmaceutical Tariffs May Have on Pharmacies Brian Nowosielski ; Marta Wosinska, PhD ; Joey Mattingly, PharmD, MBA, PhD June 12th 2025 Podcast Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, joined Drug Topics to help us understand how pharmaceutical tariffs could potentially impact the pharmacy industry.
READ MORE: Q&A: Retail, IndependentPharmacies Continue to Call for Improved Reimbursement Practices Don’t get left behind: Sign up today for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips delivered straight to your inbox.
link] Recent Videos Related Content FDA Approves Dupilumab for Treatment of Bullous Pemphigoid Ashley Gallagher June 20th 2025 Article Bullous pemphigoid is a rare skin condition that causes large blisters filled with fluids that typically occur near skin creases, such as the upper thighs and armpits. Jefferson Health. Accessed June 20, 2025.
1 "Lilly was the first company to offer a self-pay solution for an FDA-approved obesity medication, and we continue to work to expand coverage for Zepbound. mg and 15 mg vials of tirzepatide starting July 7, with shipments beginning in early August.
Not only is it important for pharmacies and their employees to have protocols for natural disasters, but pharmacies should also educate their patients on properly storing and managing their medications during a state of emergency. Taking precautions for storing medications and supplies is key to being prepared,” the FDA wrote.
Related Content Register Today: June 2025 Total Pharmacy Solutions Summit Brian Nowosielski June 2nd 2025 Article The event will focus on revenue stream diversification, providing independentpharmacies with seeds of innovation and practical tools to cultivate new avenues for growth in pharmacy.
Recent Videos Related Content Register Today: June 2025 Total Pharmacy Solutions Summit Brian Nowosielski June 2nd 2025 Article The event will focus on revenue stream diversification, providing independentpharmacies with seeds of innovation and practical tools to cultivate new avenues for growth in pharmacy.
Recent Videos Related Content Q&A: Pharmacies Grapple With Patient Influx Amid Rite Aid Closures Killian Meara ; Rob Frankil, RPh July 1st 2025 Article Rob Frankil, RPh, discusses how independentpharmacies in Pennsylvania are dealing with the impact of Rite Aid stores closing.
link] Recent Videos Related Content FDA Grants Expanded Interchangeability Designation to Yuflyma Ashley Gallagher May 23rd 2025 Article Adalimumab-aaty (Yuflyma) prefilled syringes and autoinjectors are now fully interchangeable with the reference product adalimumab (Humira) across marketed dosage forms and strengths.
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)
Statins Have No Additional Antidepressive Effects as Add-On Treatment Ashley Gallagher June 5th 2025 Article Investigators found that simvastatin added to escitalopram for patients with obesity and major depressive disorder did not have increased antidepressive effects.
FDA Approves Roflumilast Foam For Plaque Psoriasis of Scalp, Body Ashley Gallagher May 22nd 2025 Article The supplemental new drug application for roflumilast (Zoryve) is approved for adult and pediatric patients 12 years and older.
Dapagliflozin Improves Health Outcomes for Adolescents With Type 1 Diabetes Ashley Gallagher June 19th 2025 Article The drug could also reduce chronic kidney disease when combined with insulin therapy.
Low Sodium DASH Diet May Reduce Blood Pressure in Patients With T2D Killian Meara June 10th 2025 Article A modified DASH diet with lower sodium optimized for patients with type 2 diabetes reduced both systolic and diastolic blood pressure.
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)
HIV Drug Shows Potential as Oral Treatment for Diabetic Macular Edema Ashley Gallagher May 30th 2025 Article The results show promise, as vision typically improves the most during the first 4 weeks, but with lamivudine, vision continued to improve in the following 4 weeks.
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)
3,4 Since then, several other formulations have received FDA approval, leading to research developments of multiple GLP-1s for treating people with overweight or obesity. image credit: photoopus / stock.adobe.com The first GLP-1RA approved for use in the US was exenatide (Byetta) in 2005 for patients with type 2 diabetes (T2D).
READ MORE: FDA Approves Roflumilast Foam For Plaque Psoriasis of Scalp, Body The current treatment guidelines for patients with psoriasis include a variety of pharmacological options, such as biologics, phototherapy, and topicals.
Procedure Shows Promise for Sustained Weight Loss After GLP-1 Therapy Ashley Gallagher June 25th 2025 Article Revita is a procedure that modifies duodenal dysfunction and restores metabolic health, according to Fractyl Health. $0
Independentpharmacies can play a significant role in helping local communities prepare for back to school. As a local independentpharmacy owner, you can help prevent and treat common ailments arising from back to school activities. A great FDA-registered device called the V-Comb is a hot seller too.
Statins Have No Additional Antidepressive Effects as Add-On Treatment Ashley Gallagher June 5th 2025 Article Investigators found that simvastatin added to escitalopram for patients with obesity and major depressive disorder did not have increased antidepressive effects.
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)
Diabetes Risk Reduction Practices Low for Women With Gestational Diabetes Ashley Gallagher June 13th 2025 Article For women in rural populations, access to education and care is limited, causing disparities in diabetes care.
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)
FDA Approves Roflumilast Foam For Plaque Psoriasis of Scalp, Body Ashley Gallagher May 22nd 2025 Article The supplemental new drug application for roflumilast (Zoryve) is approved for adult and pediatric patients 12 years and older.
Risk of Adverse Pregnancy Outcomes Increases With Hepatitis B, Gestational Diabetes Ashley Gallagher June 9th 2025 Article Hepatitis B and liver functions have been found to be independent risk factors for gestational diabetes and are found to have the highest prevalence of abnormalities.
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)
Small Dispensers and the 6/12/2024 FDA Announcement Concerning DSCSA This week’s article on the recent DSCSA postponement comes from PRS Pharmacy Services. If the Pharmacy returns products to the ATP they purchased from, the 3Ts do not need to be provided. We need more clarity here to see what the FDA is planning.
Caremark treats coupons for Rx Only supplements and devices differently than it does for FDA-approved drugs. To use a manufacturer coupon with any Caremark claim, the product must be an FDA-approved DRUG. This loss of contract would devastate most independentpharmacies. What primary insurance does the patient have?
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)
Independentpharmacies have emerged as pivotal players in this arena, offering point-of-care testing (POCT) services that not only enhance healthcare accessibility but also alleviate the strain on hospitals and healthcare systems. While it offers moderate sensitivity, recent FDA regulations mandate higher sensitivity thresholds.
Help your patients access the hottest weight loss medications with these semaglutide and tirzepatide resources for independentpharmacy owners, whether you compound or not. I gathered all the helpful resources so independentpharmacies everywhere can help patients get the medications they need to achieve their weight loss goals.
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)
By requiring standardized documentation and communication protocols, the DSCSA makes it quicker and more efficient for pharmaceutical manufacturers and distributors to initiate recalls and notify relevant parties, including healthcare providers and the FDA (Food and Drug Administration). DiversifyRx members can get a discount with LSPedia.
Rite Aid, which was once the third largest pharmacy chain in the United States, announced in May that it filed its second chapter 11 bankruptcy in under 2 years. Drug Topics : How has the closure of Rite Aid stores impacted independentpharmacies in Pennsylvania? Rob Frankil, RPh : I'm seeing a mixed bag.
pharmacies by U.S. The survey of chain and independentpharmacies across all 50 states, which was conducted last month, found a third of drug stores charged $164 or more to uninsured patients for Lilly’s Insulin Lispro. The highest-priced pharmacy wanted $330. Elizabeth Warren’s office released on Thursday.
Should You Keep Compounding GLP1s (Tirzepatide or Semaglutide) After the FDA Deadline? Howdy pharmacy peeps… Lets have a real talk about compounding GLP1s. Deadlines For Compounding GLP1s (Semaglutide & Tirzepatide) Stay up to date on the FDA’s opinion at their website HERE. Here’s My Take.
It’s in a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists, approved by the Food and Drug Administration (FDA) to manage blood sugar levels in adults with Type 2 diabetes when combined with diet and exercise. If you’re willing to trade convenience for savings, you can compare local pharmacy costs.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content